We are live on
!
Find out more
O
Ossiam Portfolio holdings
AUM
$7.54B
1-Year Est. Return
50.81%
This Fund
S&P 500
This Quarter
Est. Return
-2.38%
1 Year Est. Return
+50.81%
3 Year Est. Return
+154.61%
5 Year Est. Return
+182.64%
10 Year Est. Return
–
AUM
$5.66B
AUM Growth
+$93.2M
(+1.7%)
Cap. Flow
+$263M
Cap. Flow
% of AUM
4.64%
Top 10 Holdings %
Top 10 Hldgs %
34.42%
Holding
739
New
29
Increased
347
Reduced
276
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$184M |
| 2 |
Snap
SNAP
|
+$127M |
| 3 |
Citigroup
C
|
+$125M |
| 4 |
Tesla
TSLA
|
+$108M |
| 5 |
Microsoft
MSFT
|
+$99.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$127M |
| 2 |
Johnson & Johnson
JNJ
|
+$104M |
| 3 |
Apple
AAPL
|
+$93M |
| 4 |
McDonald's
MCD
|
+$73.3M |
| 5 |
Automatic Data Processing
ADP
|
+$62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 21.97% |
| 2 | Technology | 20.92% |
| 3 | Consumer Discretionary | 20.44% |
| 4 | Financials | 16.51% |
| 5 | Consumer Staples | 5.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
AbbVie
ABBV
$443B
| $7.89M | 0.14% |
52,961
+17,934
| +51% | +$2.63M |
|
102
AT&T
T
$172B
| $7.37M | 0.13% |
490,642
+382,004
| +352% | +$5.6M |
|
103
Royal Bank of Canada
RY
$286B
| $7.15M | 0.13% |
81,458
-26,979
| -25% | -$2.51M |
|
104
Expedia Group
EXPE
$32.7B
| $7.05M | 0.12% |
68,412
-225,073
| -77% | -$24.8M |
|
105
Cisco
CSCO
$431B
| $6.97M | 0.12% |
129,732
+47,084
| +57% | +$2.54M |
|
106
Toronto Dominion Bank
TD
$195B
| $6.77M | 0.12% |
111,892
+19,764
| +21% | +$1.23M |
|
107
Broadcom
AVGO
$1.73T
| $6.63M | 0.12% |
79,860
-20,360
| -20% | -$1.76M |
|
|
SGEN
108
DELISTED
Seagen Inc. Common Stock
SGEN
| $6.61M | 0.12% |
31,155
-686
| -2% | -$137K |
|
109
Nucor
NUE
$58.5B
| $6.43M | 0.11% |
41,142
+37,677
| +1,087% | +$6.24M |
|
110
Essex Property Trust
ESS
$17.6B
| $6.13M | 0.11% |
28,899
-23,011
| -44% | -$5.39M |
|
111
Boston Scientific
BSX
$65.2B
| $5.7M | 0.1% |
108,032
-3,168
| -3% | -$166K |
|
112
Canadian Pacific Kansas City
CP
$79.2B
| $5.59M | 0.1% |
+74,845
| New | +$5.94M |
|
113
TJX Companies
TJX
$139B
| $5.41M | 0.1% |
60,836
-308,881
| -84% | -$27.2M |
|
114
Coca-Cola
KO
$377B
| $5.39M | 0.1% |
96,320
-615,261
| -86% | -$36.9M |
|
115
Franklin Templeton
BEN
$17.3B
| $5.23M | 0.09% |
212,910
-1,228,434
| -85% | -$33.2M |
|
116
Bristol-Myers Squibb
BMY
$132B
| $5.19M | 0.09% |
89,389
+18,315
| +26% | +$1.12M |
|
117
Qorvo
QRVO
$9.28B
| $5.12M | 0.09% |
53,602
-1,248
| -2% | -$127K |
|
118
CME Group
CME
$98.8B
| $5.06M | 0.09% |
25,284
+5,476
| +28% | +$1.09M |
|
119
American Express
AXP
$217B
| $4.8M | 0.08% |
32,159
+13,970
| +77% | +$2.29M |
|
120
UBS Group
UBS
$168B
| $4.67M | 0.08% |
188,419
-17,776
| -9% | -$415K |
|
121
International Flavors & Fragrances
IFF
$21.5B
| $4.66M | 0.08% |
68,419
+44,889
| +191% | +$3.28M |
|
122
Travelers Companies
TRV
$76.5B
| $4.48M | 0.08% |
27,428
+21,372
| +353% | +$3.57M |
|
123
Thermo Fisher Scientific
TMO
$224B
| $4.44M | 0.08% |
8,770
-27,872
| -76% | -$14.9M |
|
124
Oracle
ORCL
$466B
| $4.37M | 0.08% |
41,296
+1,486
| +4% | +$172K |
|
125
Accenture
ACN
$108B
| $4.35M | 0.08% |
14,174
-1,586
| -10% | -$500K |
|
Similar funds
HPC
CCM
RIG
TAM
EDRH
CIA
S
EAM
Ossiam's Q3 2023 Portfolio in Review
As of Q3 2023, Ossiam held 739 positions worth $5.66B, up 1.7% from $5.57B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ossiam deployed $263M of net new capital in Q3 2023, opening 29 new positions and adding to 347 existing holdings. Its largest new stake was Denbury Inc.: 194,056 shares worth $19M.
By sector, the portfolio is most concentrated in Communication Services at 22% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $127M trimmed.
- Ossiam's largest Q3 2023 buy was Denbury Inc.: 194,056 shares worth $19M.
- Ossiam added most to Meta Platforms (Facebook) in Q3 2023, an estimated $184M increase.
- Ossiam's biggest Q3 2023 reduction was UnitedHealth, cutting an estimated $127M.
- Ossiam fully exited RB Global in Q3 2023, selling an estimated $22M.
- Ossiam's ten largest holdings make up 34% of its $5.66B portfolio in Q3 2023.
- Ossiam opened 29 new positions and closed 74 in Q3 2023.
- Ossiam's portfolio value rose 1.7% quarter-over-quarter to $5.66B.
Based on Ossiam's 13F filing for Q3 2023, filed 14 Nov 2023.